| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: RNA Viruses |
CNRS-UMR 85261 and CNRS-UMR 85252, Institut de Biologie de Lille/Institut Pasteur de Lille, BP447, 59021 Lille cedex, France
Author for correspondence: Jean Dubuisson.Fax +33 3 20 87 11 11. e-mail jean.dubuisson{at}ibl.fr
Hepatitis C virus (HCV) encodes two glycoproteins, E1 and E2, which assemble in oligomeric structures. Studies of HCV glycoprotein assembly using heterologous expression systems have shown that these glycoproteins can follow two pathways: a productive pathway leading to the formation of a non-covalent heterodimer; and a non-productive pathway leading to the formation of large disulfide-linked aggregates. The non-covalent HCV glycoprotein complex is probably the functional complex which plays an active role in the entry process in host cells. The aggregates are believed to be waste products; however, one can imagine that, in infected cells, they could provide HCV glycoproteins with additional functions. To further understand the potential role played by HCV glycoprotein aggregates in HCV infection, a MAb (H14) was produced which specifically recognizes these aggregates but not the non-covalent E1E2 heterodimer. The H14 epitope was shown to be present on both HCV glycoproteins and was sensitive to deglycosylation. An additional characterization of HCV glycoprotein aggregates, with the help of MAb H14, indicates that they share an epitope with a cellular protein called Mac-2 binding protein. The presence of such an epitope on HCV glycoprotein aggregates could potentially lead to the production of autoantibodies recognizing Mac-2 binding protein in HCV-infected patients.
This article has been cited by other articles:
|
|
 |
|
  J M Timpe and J A McKeating Hepatitis C virus entry: possible targets for therapy Gut, December 1, 2008; 57(12): 1728 - 1737. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chapel, C. Garcia, B. Bartosch, P. Roingeard, N. Zitzmann, F.-L. Cosset, J. Dubuisson, R. A. Dwek, C. Trepo, F. Zoulim, et al. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors J. Gen. Virol., April 1, 2007; 88(4): 1133 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Owsianka, A. W. Tarr, V. S. Juttla, D. Lavillette, B. Bartosch, F.-L. Cosset, J. K. Ball, and A. H. Patel Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein J. Virol., September 1, 2005; 79(17): 11095 - 11104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. U. Nielsen, M. F. Bassendine, A. D. Burt, D. J. Bevitt, and G. L. Toms Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver J. Gen. Virol., June 1, 2004; 85(6): 1497 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Op De Beeck, C. Voisset, B. Bartosch, Y. Ciczora, L. Cocquerel, Z. Keck, S. Foung, F.-L. Cosset, and J. Dubuisson Characterization of Functional Hepatitis C Virus Envelope Glycoproteins J. Virol., March 15, 2004; 78(6): 2994 - 3002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lucas, E. Tsitoura, M. Montoya, B. Laliotou, E. Aslanoglou, V. Kouvatsis, C. Entwisle, J. Miller, P. Klenerman, A. Hadziyannis, et al. Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus J. Gen. Virol., March 1, 2003; 84(3): 545 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cocquerel, E. R. Quinn, M. Flint, K. G. Hadlock, S. K. H. Foung, and S. Levy Recognition of Native Hepatitis C Virus E1E2 Heterodimers by a Human Monoclonal Antibody J. Virol., December 20, 2002; 77(2): 1604 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Molenkamp, E. A. Kooi, M. A. Lucassen, S. Greve, J. C. P. Thijssen, W. J. M. Spaan, and P. J. Bredenbeek Yellow Fever Virus Replicons as an Expression System for Hepatitis C Virus Structural Proteins J. Virol., December 20, 2002; 77(2): 1644 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Clayton, A. Owsianka, J. Aitken, S. Graham, D. Bhella, and A. H. Patel Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles J. Virol., June 27, 2002; 76(15): 7672 - 7682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tsitoura, M. Lucas, V. Revol-Guyot, A. L. Epstein, R. Manservigi, and P. Mavromara Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors J. Gen. Virol., March 1, 2002; 83(3): 561 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Op De Beeck, L. Cocquerel, and J. Dubuisson Biogenesis of hepatitis C virus envelope glycoproteins J. Gen. Virol., November 1, 2001; 82(11): 2589 - 2595. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Op De Beeck, R. Montserret, S. Duvet, L. Cocquerel, R. Cacan, B. Barberot, M. Le Maire, F. Penin, and J. Dubuisson The Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins E1 and E2 Play a Major Role in Heterodimerization J. Biol. Chem., September 29, 2000; 275(40): 31428 - 31437. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
